Novonesis

Supplier
Summarized by Halo AI

Novonesis is a leading global biosolutions company that leverages microbiology and fermentation to transform how the world produces, consumes, and lives, serving over 30 industries with sustainable, science-based solutions.

Company size
~11,000 employees
Revenue
~EUR 4.2B (2025)
Portfolio summary
Enzymes, microbes, probiotics, prebiotics, human milk oligosaccharides (HMOs), postbiotics, novel vitamins, and protein ingredients for food, beverages, human health, and planetary health applications
Markets served
APAC · EMEA · LATAM · NA
Manufacturing locations
30 production sites across four continents
R&D locations
Hørsholm, Denmark (Innovation Campus & Dairy Application Technology Center) · Bagsvaerd, Denmark · Gladsaxe, Denmark · Davis, CA, United States · Salem, VA, United States · Franklinton, NC, United States · Thebarton, Australia · Beijing, China · Bangalore, India · Araucária, Brazil

Novonesis is a global biosolutions company formed in 2024 through the combination of Chr. Hansen and Novozymes. The organization specializes in microbiology and industrial fermentation, developing a diverse range of biosolutions used across more than 30 industries, including food and nutrition, agriculture, household care, and energy. By leveraging science and the power of biology, Novonesis creates innovations that help customers reduce their reliance on fossil-based resources, chemicals, energy, and water. The company operates with a purpose to better the world with biology, focusing on sustainable production and consumption patterns.

For customers and partners, Novonesis provides tailored solutions supported by deep scientific expertise and flexible, global production capabilities. The company serves as a strategic partner, enabling clients to achieve higher yields, improve resource efficiency, and differentiate their own products in the marketplace. With over 11,000 employees worldwide, Novonesis utilizes data-driven insights and AI to accelerate its research and development, ensuring it remains at the forefront of the biosolutions sector and continues to drive long-term value for stakeholders across the globe.

AI summary generated on Jun 11, 2026
OpenAlexOpenAlex
Is this page yours? Boost its visibility
List technologies, facilities, services, or grant collaboration opportunities.

Looking for

Co-developmentSupply/purchaseFee-for-service

Key links

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.